Dr. Fatima Al Kaabi

Director General, Emirates Drug Establishment

Executive Director, Abu Dhabi Bone Marrow Transplant Program at ADSCC
Vice-Chair, UAE National Multiple Sclerosis Society
Chairperson, UAE BIOTECH Research Center

Share

Dr. Fatima Al Kaabi has been appointed as the Director General of the Emirates Drug Establishment. Serving concurrently as the Executive Director of the Abu Dhabi Bone Marrow Transplant Program (AD-BMT^©) at Abu Dhabi Stem Cells Center since 2019, Dr. Al Kaabi is a leading figure in UAE’s healthcare sector. She is also the Vice-Chair of the UAE National Multiple Sclerosis Society Board of Trustees and the Chairperson of UAE BIOTECH Research Center.

Her academic journey includes earning an MPH from Johns Hopkins University in 2001 and an MSc in Cancer from University College London in 2012. Furthermore, she completed her fellowship in hematology in the Royal Free Hospital in the United Kingdom.

Previously, Dr. Al Kaabi held multiple leadership positions including the Executive Director of Emirates Genome and Health Affairs at Abu Dhabi Executive Office (ADEO); Head of Adult Hematology/Oncology and Deputy Chief Medical Officer at Sheikh Khalifa Medical City (SKMC) in Abu Dhabi. In her current roles, Dr. Al Kaabi continues to make significant contributions to the healthcare sector, leveraging her experience and dedication to drive positive change and advancements in the field.